“…In pharmaceutical development, over 40% of newly synthesized candidate therapeutics fall under BCS II or BCS IV, categories notorious for their poor water solubility (Charalabidis et al, 2019), particularly compounds originating from natural plants. These plant-derived derivatives (e.g., paclitaxel, resveratrol, and curcumin) have demonstrated a plethora of functional diversity and therapeutic potential, finding applications in the food industry, biopharmaceuticals, and adjacent sectors (Li and Vederas, 2009;Kundu et al, 2021;Cruz-Hernández et al, 2022). Nevertheless, these compounds all exhibit poor bioavailability due to their low aqueous solubility.…”